Inclusion Criteria:  psoriasis obese patients with coexisting fatty liver chronic plaque psoriasis patients who will not show any change in immuno-modulating psoriasis therapies for at least five months before participation in the study.  Exclusion Criteria:  no metabolic syndrome no renal or cardiac or pulmonary disorders other types of psoriasis